Insider Transactions in Q1 2025 at Capricor Therapeutics, Inc. (CAPR)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2025
|
Linda Marban CHIEF EXECUTIVE OFFICER |
SELL
Other acquisition or disposition
|
Direct |
12,500
-5.59%
|
-
|
|
Mar 03
2025
|
Linda Marban CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.06%
|
$25,000
$1.39 P/Share
|
|
Mar 03
2025
|
George W Dunbar Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+6.22%
|
$750
$1.39 P/Share
|
|
Mar 03
2025
|
Frank Litvack |
SELL
Payment of exercise price or tax liability
|
Direct |
2,543
-1.92%
|
$33,059
$13.67 P/Share
|
|
Mar 03
2025
|
Frank Litvack |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+15.88%
|
$25,000
$1.39 P/Share
|
|
Mar 03
2025
|
Anthony Bergmann CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+23.31%
|
$2,500
$1.39 P/Share
|
|
Feb 27
2025
|
Earl M Collier Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+1.29%
|
$750
$1.39 P/Share
|
|
Jan 02
2025
|
Anthony Bergmann CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,342
+36.87%
|
-
|